Introduction {#Sec1}
============

Both, the progression of atherosclerotic plaque volume and unfavorable plaque tissue characteristics contribute to the overall risk of cardiovascular events \[[@CR1]--[@CR5]\]. Previous progression-regression studies with intravascular ultrasound (IVUS) reported a certain beneficial effect of anti-atherosclerotic pharmacological therapies on the progression of plaque volume; however, this can only partly explain the clinical benefit observed \[[@CR6]--[@CR10]\]. While conventional grey-scale IVUS permits accurate quantification of plaque and vessel dimensions, it has significant limitations in the assessment of plaque composition \[[@CR6], [@CR7], [@CR11]--[@CR15]\].

As a consequence, a spectral analysis of IVUS radiofrequency (RF-IVUS) data has been developed and is increasingly used in clinical research \[[@CR16]--[@CR22]\]. RF-IVUS quantifies coronary plaque components (e.g., the necrotic core) with a high predictive accuracy, as demonstrated in vitro and in vivo \[[@CR23]--[@CR25]\].

Volumetric RF-IVUS data may be interesting endpoints of IVUS studies that evaluate anti-atherosclerotic pharmacological therapies \[[@CR26]\]. However, there is a lack of information on the reproducibility of this approach \[[@CR17]\]. Therefore, we assessed in atherosclerotic human coronary segments the reproducibility of *volumetric* RF-IVUS in vivo by comparing analyses from the same pullback, repeated pullbacks, and by different observers.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

To assess the reproducibility of segmental IVUS-RF data analysis in mild-to-moderately diseased atherosclerotic human coronary arteries in vivo, we repeatedly analyzed IVUS data sets of 33 at least 20 mm-long coronary segments from non-target and non-treated coronary arteries with an angiographic lumen diameter stenosis \<50% and absence of severe calcification or vessel tortuosity. Two motorized IVUS pullbacks at a speed of 0.5 mm/s were available from 16 patients in regular sinus rhythm in whom clinically-driven, elective diagnostic cardiac catheterizations (n = 10) or percutaneous coronary interventions (n = 6) required IVUS assessment. Informed consent was obtained prior to cardiac catheterization from all patients in accordance with the directives of the Local Medical Ethics Committee.

RF-IVUS {#Sec4}
-------

Details regarding the RF-IVUS technique, also known as virtual histology IVUS, and validation have previously been described \[[@CR16], [@CR17], [@CR23]--[@CR25]\]. In brief, spectral analysis of IVUS radiofrequency data is used to create tissue maps in order to classify atherosclerotic plaques into four major components (fibrous, fibro-lipidic, calcium, and necrotic-core). Different plaque components were represented according to a dedicated color code (green, light-green, white and red) (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Image data acquisition and analysis. The R-wave peak of the ECG triggered image acquisition during a motorized pullback at a speed of 0.5 mm/s (**A**). Automated contour detection of the luminal and vessel borders was performed on all IVUS images acquired. A longitudinal reconstruction of the segment was obtained from the entire three-dimensional "stack" of images (**B**). The direction of the longitudinal reconstruction was indicated by an arrowhead on the cross-sectional images. All contours were checked on the cross-sectional frame and manual correction could be performed (**C**). VH-IVUS analysis revealed (colour-encoded) information on plaque composition from the space between the lumen and vessel borders; volumetric data of the geometrical vessel dimension and of plaque composition were automatically generated for the segment (**D**)

RF-IVUS acquisition {#Sec5}
-------------------

RF-IVUS data was acquired with commercially available phased-array IVUS catheters (Eagle Eye Gold 2.9F 20 MHz, Volcano Corporation, Rancho Cordova, USA) by a dedicated RF-IVUS console (Volcano Therapeutics, Rancho Cordova, USA). The image acquisition was ECG-gated (Fig. [1](#Fig1){ref-type="fig"}). The catheter probe was advanced ≥10 mm distal to the most distal side-branch. Angiographic cine runs were performed to define the position of the IVUS catheter. After intracoronary injection of 200 μg nitroglycerine, a continuous pullback of the IVUS catheter was performed using a motorized pullback device at 0.5 mm/s (TrackBackII, Volcano Corporation, Rancho Cordova, USA). In the patients of the present study, a second pullback was performed using the same IVUS catheter. Data of both pullbacks were stored on hard disk.

RF-IVUS analysis {#Sec6}
----------------

RF-IVUS analysis was performed off-line by two experienced IVUS analysts (M.H., E.S.K.M.). The *first* pullback (I) was divided into segments as the region of interest. Segments were located between two adjacent side-branches and contained no major calcification that could have limited quantitative assessment of vessel cross-sectional area. Subsequently, the same segment was identified in the *second* pullback (II) using side-by-side comparison of longitudinal and cross-sectional views. In fact, this approach was similar to the matching procedure as applied in serial IVUS studies \[[@CR7]--[@CR10]\]. The time required for the matching procedure was recorded. The vessel borders were traced using a semi-automatic contour detection program (IVUSLab 4.4, Volcano Corporation, Rancho Cordova, USA).

The borders of each cross-sectional image per segment were manually corrected if required to meet a high standard of accuracy. The lumen border was detected by tracing the leading edge of the intima, and the total vessel border by tracing the leading edge of the adventitia. Plaque + media (total vessel − lumen) was used as a measure of atherosclerotic plaque \[[@CR11], [@CR12]\]. The time required for the correction of the computerized contour detection was recorded. For each coronary segment, the vessel geometrics (lumen, total vessel and plaque + media volume) and the volumetric compositional RF-IVUS (fibrous, fibro-lipidic, calcium, and necrotic-core) were generated by applying Simpson's rule (Fig. [1](#Fig1){ref-type="fig"}) \[[@CR22], [@CR27]\]. Volumetric plaque burden (%) was calculated as \[(plaque volume/total vessel volume) × 100\].

Each segment of the first pullback (I) was analyzed twice by the 1st observer (Ia and Ib) and once by the 2nd observer (Ic) after re-defining the segments of the first pullback; the corresponding segment of the second pullback (II) was analyzed once by the 1st observer.

Data analysis {#Sec7}
-------------

First, we compared repeated RF-IVUS measurements (volumetric vessel geometrics and composition) from the *first* pullback analyzed by the 1st observer (intraobserver comparison, Ia versus Ib). Second, we compared the RF-IVUS measurements from the *first* and *second* pullback analyzed by the 1st observer (intraobserver comparison, Ia versus II). Third, we compared RF-IVUS measurements from the *first* pullback between the 1st and 2nd observer (interobserver comparison, Ia versus Ic).

Statistical analysis {#Sec8}
--------------------

Analyses were performed with SPSS 13.0 (SPSS Inc., Chicago, Illinois). Dichotomous data are presented as frequencies. Quantitative data are presented as mean ± 1 SD and compared using student t-test, linear regression analysis, or ANOVA for repeated measures with post hoc testing with Tukey honestly significant difference test. According to Bland and Altman, the agreement between two measurements were assessed by determining the mean ± 2 SD of the between measurement differences \[[@CR28]\]. A two-sided *P*-value \<0.05 was considered significant.

Results {#Sec9}
=======

Study population {#Sec10}
----------------

Thirty-three atherosclerotic coronary segments (six proximal and six in the mid right, seven proximal and six in the mid left anterior descending, five proximal and three in the mid left circumflex coronary artery, respectively) from 16 patients with stable angina (11 men, age 58 ± 8 years) were included. The heart rate was 69 ± 14 bpm. There were no complications related to the IVUS investigation.

RF-IVUS analysis and data {#Sec11}
-------------------------

A total of 9,212 cross-sectional IVUS analyses were performed (70 ± 21 frames/segment). Manual correction of the automatic border detection was required in 96 ± 6% of frames/segment within 40 ± 11 min/segment. Matching the segments of interest between the repeated pullbacks I and II required 13 ± 5 min/segment.

The length of the segments was 27 ± 7 mm (range: 20--46 mm) with a volumetric plaque burden of 36 ± 8% (range: 23--55%). The atherosclerotic segments contained pre-dominantly fibrous (47%) and necrotic-core (25%) tissue. Further data are presented in Table [1](#Tab1){ref-type="table"}.Table 1Volumetric RF-IVUS measurements of vessel geometrics and plaque composition of 1st and 2nd observer1st Observer2nd ObserverPullback IaPullback IbPullback IIPullback IcVessel geometrics    Total vessel volume (mm³)458.98 ± 118.1460.24 ± 116.3460.85 ± 118.1456.27 ± 119.6    Lumen volume (mm³)290.05 ± 77.7291.11 ± 76.8291.33 ± 77.5288.09 ± 77.9    Plaque + media volume (mm³)168.93 ± 70.4169.12 ± 69.0169.32 ± 70.3168.17 ± 72.3    Plaque burden (%)36.36 ± 8.336.33 ± 8.236.31 ± 8.236.34 ± 8.5Plaque composition    Fibrous volume (mm^3^)34.06 ± 32.034.10 ± 32.033.68 ± 31.734.35 ± 32.1    Fibrous (%)46.62 ± 15.546.44 ± 15.846.64 ± 15.846.98 ± 15.3    Fibro-lipidic volume (mm^3^)5.66 ± 7.75.70 ± 7.95.55 ± 7.55.49 ± 7.2    Fibro-lipidic (%)6.94 ± 4.86.82 ± 4.76.93 ± 4.66.67 ± 4.8    Calcium volume (mm^3^)12.46 ± 9.512.48 ± 9.312.36 ± 9.512.48 ± 9.9    Calcium (%)21.85 ± 11.721.98 ± 11.821.73 ± 11.821.40 ± 11.6    Necrotic-core volume (mm^3^)15.94 ± 13.516.00 ± 13.515.77 ± 13.116.15 ± 13.3    Necrotic-core (%)24.59 ± 8.524.62 ± 8.724.70 ± 8.624.83 ± 8.7

Reproducibility of geometrical RF-IVUS (intraobserver and interobserver comparison) {#Sec12}
-----------------------------------------------------------------------------------

Data on the agreement and variability of repeated geometrical RF-IVUS measurements (absolute and/or relative differences) showed a high reproducibility (Table [2](#Tab2){ref-type="table"} and Fig. [2](#Fig2){ref-type="fig"}). Repeated geometrical measurements were highly correlated for intraobserver comparison from the same pullback and repeated pullbacks, and for the interobserver comparison (r ≥ 0.999, ≥ 0.997, and ≥ 0.995; *P* \< 0.001 for all; data not shown).Table 2Intra- and interobserver measurement differences of volumetric vessel geometrics and plaque compositionIntraobserver comparison (same pullback)\
Ia versus IbIntraobserver comparison (repeated pullback)\
Ia versus IIInterobserver comparison (same pullback)\
Ia versus IcANOVA *PP*1*P*2*P*3Vessel geometrics    ∆Total vessel volume (mm³)−1.25 ± 3.8\*−1.67 ± 4.9\*2.72 ± 8.0\***\<0.01**NS**\<0.05\<0.01**    % ∆Total vessel volume (%)−0.40 ± 1.0−0.42 ± 1.20.71 ± 1.8**\<0.01**NS**\<0.01\<0.01**    ∆Lumen volume (mm³)−1.06 ± 3.5\*−1.28 ± 5.1\*1.95 ± 6.5\***\<0.05**NSNS**\<0.05**    % ∆Lumen volume (%)−0.48 ± 1.4−0.52 ± 1.80.71 ± 2.2**\<0.01**NS**\<0.05\<0.05**    ∆Plaque + media volume (mm³)−0.19 ± 2.9\*−0.39 ± 5.8\*0.76 ± 7.5\*0.7------    % ∆Plaque + media volume (%)−0.35 ± 1.6−0.43 ± 4.50.89 ± 5.00.3------    ∆Plaque burden (%)0.03 ± 0.5\*0.05 ± 1.2\*0.02 ± 1.4\*0.9------    % ∆Plaque burden (%)0.04 ± 1.40.01 ± 3.70.20 ± 4.20.9------Plaque composition    ∆Fibrous volume (mm³)−0.04 ± 0.7\*0.38 ± 2.0\*−0.28 ± 1.0\*0.1------    % ∆Fibrous volume (%)0.45 ± 2.11.40 ± 4.1−1.60 ± 4.9**\<0.01**NSNS**\<0.01**    ∆Fibrous (%)0.18 ± 0.6\*−0.02 ± 1.2\*−0.37 ± 1.5\*0.1------    % ∆Fibrous (%)0.75 ± 1.70.24 ± 2.8−1.00 ± 4.20.1------    ∆Fibro-lipidic volume (mm^3^)−0.04 ± 0.3\*0.12 ± 0.5\*0.17 ± 0.8\*0.6------    % ∆Fibro-lipidic volume (%)−1.12 ± 4.91.26 ± 6.73.85 ± 8.2**\<0.01**NS**\<0.01\<0.01**    ∆Fibro-lipidic (%)0.11 ± 0.8\*0.00 ± 0.6\*0.27 ± 0.9\*0.6------    % ∆Fibro-lipidic (%)0.27 ± 8.2−0.07 ± 5.86.03 ± 9.1**\<0.01**NS**\<0.05\<0.01**    ∆Calcium volume (mm^3^)−0.01 ± 0.3\*0.10 ± 0.8\*−0.02 ± 1.0\*0.6------    % ∆Calcium volume (%)−0.84 ± 2.12.66 ± 7.41.66 ± 7.50.1------    ∆Calcium (%)−0.13 ± 0.4\*0.12 ± 1.3\*0.45 ± 1.5\*0.1------    % ∆Calcium (%)−0.51 ± 1.71.52 ± 6.72.26 ± 6.90.1------    ∆Necrotic-core volume (mm^3^)−0.05 ± 0.4\*0.18 ± 0.8\*−0.21 ± 0.8\*0.1------    % ∆Necrotic-core volume (%)−0.22 ± 1.80.85 ± 4.4−1.58 ± 4.70.1------    ∆Necrotic-core (%)−0.03 ± 0.4\*−0.11 ± 1.0\*−0.23 ± 0.8\*0.9------    % ∆Necrotic-core (%)0.07 ± 1.8−0.34 ± 3.6−0.90 ± 3.40.4------P1 = Ia versus Ib vs. Ia versus II; P2 = Ia versus Ib vs. Ia versus Ic; and P3 = Ia versus II vs. Ia versus Ic. \*Paired t-test Ia versus Ib; Ia versus II; and Ia versus Ic *P* = NS for all. ∆ = differenceSignificant *P*-values are represented in boldFig. 2Agreement of repeated VH-IVUS measurements of geometrical vessel volumes. Bland--Altman plots of intra- (left, mid) and interobserver (right) comparisons. ∆ = difference

The limits of agreement (i.e., 2 SD of mean difference), which indicate the expected relative difference between two measurements (Fig. [2](#Fig2){ref-type="fig"}), were higher for two observers who analyzed the same IVUS pullback than for the same observer who analyzed repeated pullbacks, with significantly lower relative differences for total vessel and lumen volume (*P* \< 0.01 for both, Table [2](#Tab2){ref-type="table"}).

Reproducibility of compositional RF-IVUS (intraobserver and interobserver comparison) {#Sec13}
-------------------------------------------------------------------------------------

Data on the agreement and variability of repeated compositional measurements (absolute and/or relative differences) as presented in Table [2](#Tab2){ref-type="table"} and Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"} showed an acceptable reproducibility. Repeated compositional measurements were highly correlated for intraobserver comparison from the same pullback and repeated pullbacks, and for the interobserver comparison (r ≥ 0.999, ≥ 0.997, and ≥ 0.995; *P* \< 0.001 for all; data not shown). Of note, the interobserver comparison of compositional RF-IVUS measurements showed a higher variability than the intraobserver comparison from repeated IVUS pullbacks (Fig. [3](#Fig3){ref-type="fig"}) with significantly higher relative differences for fibrous and fibro-lipidic volume (*P* \< 0.01 for both, Table [2](#Tab2){ref-type="table"}).Fig. 3Agreement of repeated VH-IVUS measurements of compositional volumes. Bland--Altman plots of intra- (left, mid) and interobserver (right) comparisons. ∆ = differenceFig. 4Relative differences of repeated compositional VH-IVUS volume measurements. The volumetric VH-IVUS measurements of plaque composition in intra- (left and mid bars) and interobserver comparisons (right bars) are displayed (mean ± 1 SD). The paired t-test Ia versus Ib; Ia versus II; and Ia versus Ic showed no significant difference (*P* = NS for all). The necrotic-core volume showed on average the lowest measurement variability

Necrotic-core volume showed on average the lowest measurement variability of all plaque components in both, intraobserver and interobserver comparisons.

Discussion {#Sec14}
==========

Why measure changes in plaque composition? {#Sec15}
------------------------------------------

Serial IVUS has become an established imaging method to measure effects of cardiovascular risk factors and drugs on coronary plaque dimensions \[[@CR6]--[@CR10], [@CR29]--[@CR31]\]. Plaque progression as measured by IVUS may be linked to a significant increase in risk of clinical events as predicted by established risk-scores \[[@CR31]\]. Therefore, IVUS derived surrogate endpoints as an alternative to clinical endpoints may expedite the process of drug development and testing \[[@CR6]\]. However, there is a contradiction between the significant clinical benefit of certain pharmacological interventions (e.g., statins) and the relatively small effect on plaque volume, which may be explained by a stabilizing effect on plaque composition \[[@CR6], [@CR7], [@CR10], [@CR26], [@CR32]\].

Intravascular ultrasound radiofrequency analysis {#Sec16}
------------------------------------------------

RF-IVUS is an imaging technique that permits the characterization and quantification of plaque components in vivo ([@CR16], [@CR17], [@CR23]--[@CR25]\]. Non-serial studies suggested a potential of RF-IVUS to detect high-risk coronary plaques (i.e., thin-cap fibroatheroma) and offered new insights into coronary pathology \[[@CR18]--[@CR22]\]. Currently, large serial IVUS studies are on the way that assess with a volumetric RF-IVUS approach changes in plaque composition to analyze the effect of atherosclerosis-modifying drugs on this new surrogate endpoint \[[@CR33]\].

Rationale for the present study and main findings {#Sec17}
-------------------------------------------------

An important prerequisite for the use of RF-IVUS data as an endpoint in serial studies is the assessment of its reproducibility \[[@CR17], [@CR34]\]. Drug-induced effects on coronary arterial dimensions and plaque composition may remain relatively small \[[@CR7]--[@CR10]\]. To date there is a lack of volumetric reproducibility data simulating a serial RF-IVUS study design (e.g., repeated pullbacks) \[[@CR17], [@CR34]\].

Therefore, we assessed in the present study the reproducibility of repeated RF-IVUS analyses of vessel geometrics and plaque composition in 33 coronary segments. The relative intraobserver difference of geometrical and compositional volumetric analyses in *repeated* pullbacks was relatively low (\<0.6% for all geometric vessel volumes; \<1% for necrotic-core and \<3% for fibrous, fibro-lipidic, and calcific plaque components) and showed good limits of agreement. Of note, the interobserver comparison of RF-IVUS of geometrical and compositional measurements from the *same* pullback showed on average a somewhat higher variability than the intraobserver comparison of *repeated* pullbacks.

Reproducibility of IVUS measurements {#Sec18}
------------------------------------

The reproducibility of *two-dimensional* RF-IVUS has been tested by Rodriguez-Granillo et al. who compared *repeated* pullbacks from 16 coronary lesions \[[@CR34]\]. The relative intraobserver difference was ≤3% for the cross-sectional area measurements of vessel geometrics; in general compositional measurements were more variable than geometrical measurements. The relative intraobserver difference was ≤6% for necrotic-core area, and 8--13% for fibrous, fibro-lipidic, and calcium areas \[[@CR34]\]. Nevertheless, a *volumetric* IVUS approach is likely to result in a higher reproducibility. Kawasaki et al. reported intra- and interobserver variabilities of *volumetric* plaque compositional measurements (\<3.6% for both) from 20 lesions from the *same* IVUS pullback by using the *Integrated Backscatter* IVUS technique, which is based on a different mathematical method compared to RF-IVUS by Virtual Histology \[[@CR17], [@CR26]\].

Variability of compositional RF-IVUS analyses is related to the variability of geometrical vessel analysis \[[@CR34], [@CR35]\]. Tissue components mainly located in the center of an atherosclerotic plaque may be less sensitive to potential variation in border detection. Factors of variability in geometrical vessel analyses in a serial study design are---besides the quality of the basic IVUS images---the quality of matching the region of interest. Matching the cross-sectional target slice from baseline and follow-up examination is much more difficult with a *two-dimensional RF-*IVUS approach \[[@CR11], [@CR15]\]. The problem of matching has been significantly reduced by the use of *volumetric* IVUS, which visualizes an entire coronary segment, permits identification of one or more landmarks (e.g., adjacent side-branches), and is the current standard method in serial IVUS trials that address atherosclerosis-modifying strategies \[[@CR7]--[@CR10], [@CR15]\].

In the present study, image acquisition was performed in an ECG-gated fashion. ECG-gated image acquisition prevents artifacts from cyclic movement of the IVUS catheter and the systolic-diastolic variation of the vessel dimensions which results in a higher reproducibility of geometrical IVUS measurements \[[@CR13]--[@CR15]\]. In agreement with our results, Okkels et al. demonstrated a high reproducibility of vessel geometrical measurements from *repeated* pullbacks using a dedicated ECG-gated volumetric grey-scale IVUS technique \[[@CR15]\].

The necrotic-core {#Sec19}
-----------------

Necrotic-core tissue is the characteristic feature of so-called RF-*IVUS derived thin-cap fibroatheroma* (TCFA) \[[@CR16]--[@CR18]\]. Observational IVUS-RF studies demonstrated an association between RF-IVUS derived TCFA and both coronary and clinical instability \[[@CR18], [@CR19], [@CR22]\]. RF-IVUS derived TCFA is generally defined as at least three consecutive two-dimensional cross-sectional frames with ≥10% necrotic-core area without evident overlying fibrous tissue and a plaque burden area of ≥40% \[[@CR18]\]. Because of the two-dimensional nature of the definition of *RF-*IVUS derived TCFA, serial assessment may be difficult as outlined above; this may result in a higher measurement variability. Besides, if the luminal border is shared by thrombus---which is more likely in coronary instability---the measurement variability of plaque and lumen dimensions may be even higher, as thrombus may be misclassified as fibrous tissue \[[@CR35]\].

A volumetric parameter that is less dependent on matching problems is the RF-*IVUS derived necrotic-core volume*. From a pathophysiological point of view the necrotic core *volume* is a very interesting target, as both the necrotic core size and its longitudinal extent are related to the risk of plaque rupture that may trigger cardiovascular events as demonstrated by histopathological studies \[[@CR4], [@CR5], [@CR36], [@CR37]\]. In agreement with these findings, Hong et al. recently found a significantly higher RF-IVUS derived necrotic-core volume in lesions of patients with acute coronary syndromes compared to patients with stable angina \[[@CR22]\]. In our study in patients with stable angina, necrotic-core volume showed on average the highest reproducibility of all plaque components. Based on pathophysiological considerations and the favorable measurement reproducibility, the parameter RF-IVUS derived necrotic-core volume has the potential to become a major imaging target of future pharmacological intervention trials with IVUS. Nevertheless, the relation between serial changes of this parameter and clinical endpoints has to be demonstrated.

Limitations {#Sec20}
-----------

To the best of our knowledge, this was the first study that tested the reproducibility of *volumetric* RF-IVUS. The number of coronary segments was limited but comparable to other studies that addressed the reproducibility of IVUS measurements \[[@CR13]--[@CR15], [@CR34], [@CR38], [@CR39]\]. All patients had stable angina pectoris. Similar to other studies with IVUS and RF-IVUS, we excluded tortuous and severely calcified vessels which could have led to non-uniform pullbacks \[[@CR34]\]. We analyzed high quality RF-IVUS image runs with limited circumferential calcification which resulted in a relatively high accuracy of total vessel border detection \[[@CR11], [@CR12]\]. Therefore, measurement reproducibility may be somewhat lower in routine clinical IVUS cases; nevertheless, the selection criteria of target segments in serial IVUS studies are similar \[[@CR7]--[@CR10]\]. Inter-catheter and inter-system variability was not addressed \[[@CR34], [@CR38], [@CR39]\]. The high accuracy of the off-line RF-IVUS analysis was achieved at the expense of manual correction of the automatically derived lumen and vessel contours; accordingly, our data may not be generalized to on-line application of RF-IVUS.

Conclusions {#Sec21}
===========

In mild-to-moderate atherosclerotic coronary artery disease, the reproducibility of volumetric compositional RF-IVUS measurements from the same pullback is relatively high, but lower than the reproducibility of geometrical IVUS measurements. Measurements from repeated pullbacks and by different observers show acceptable reproducibilities for the use in a serial study design; the volumetric measurement of the necrotic-core shows on average the highest reproducibility of the compositional RF-IVUS measurements.
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